Preliminary Full Year Results Year to 31 December 2014
The Business 2014 sales by � Well-established international specialist technology and services group division – high performance instrumentation, machinery and analytical services – market-leading expertise Tobacco Scientific Machinery Services – reputation for high service levels £24.6m £24.8m � Three core areas of operation Packaging – Scientific Services Machinery £40.5m – Packaging Machinery – Tobacco Machinery 2014 sales by � International presence – 90% of sales are non-UK destination � Main sectors of focus are nutrition, beverages, healthcare, UK pharmaceutical & tobacco Asia Europe (exc. UK) Americas Africa (exc. USA) USA 1 >>
Results: Operational Key Points Results in line with market expectations � � Improved profitability in both the Scientific Services and Packaging Machinery divisions � Tobacco Machinery impacted by geopolitical environment and weak market conditions � Continuing product development across the divisions � Analytical services business in USA continues to be hampered by ongoing delays in the introduction of tobacco testing requirements, resulting in a strategic review of options Shares admitted to trading on AIM in June 2014 � Order book at the start of the year is encouraging, but with significant second half weighting of performance expected � 2 >>
Results: Financial Key Points Sales of £89.9m (2013: £105.2m) � � Underlying PBT of £3.3m (2013: £5.4) � Underlying EPS of 11.9p (2013: 23.9p) � Net debt of £2.1m (Dec 2013: £5.2m net funds) � Proposed final dividend of 3.0p per share, taking total to 5.5p per share (2013: 5.5p) 3 >>
Financial Results Underlying PBT (£m) Sales (£m) 5.4 105.2 4.9 93.0 89.9 89.9 4.5 86.4 3.6 3.3 47.8 40.3 39.9 40.0 38.8 1.7 1.5 H2 0.8 0.6 0.8 H1 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 Underlying EPS (p) Dividend per share (p) 23.9 5.5 5.5 5.5 21.8 5.25 5.0 18.3 13.9 11.9 2.5 2.5 2.5 2.5 2.5 6.3 6.5 3.6 2.5 2.1 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 4 >>
Financial Review: Income Statement 2011 £m 2014 2013 £m £m � Sales affected mainly by challenges in the tobacco Sales 89.9 105.2 sector (Tobacco Machinery sales down by £9.8m) and Underlying operating profit* 3.4 5.5 strength of sterling (reduced reported sales by £4.0m) Commensurate reduction in underlying operating profit � Non-underlying items (2.8) (0.9) Non-underlying items include pension administration � Operating profit 0.6 4.6 costs (£0.9m), reorganisation costs (£0.5m) and Net interest expense (0.3) (0.8) goodwill impairment in respect of analytical services business (£1.6m) Profit before tax 0.3 3.8 Net interest is mainly pensions related (£0.2m; � Taxation (0.6) (0.3) treated as non-underlying) (Loss)/profit for the period (0.3) 3.5 � Taxation rate of 31% on underlying profits Underlying EPS* 11.9p 23.9p (2013: 14%) Basic EPS (1.3)p 18.0p * Before non-underlying items 5 >>
Financial Review: Cash Flows 2014 2013 £m £m Cash flows from operating activities: � Cash flows from operating activities (0.5) 4.1 – £3.7m working capital increase reflecting lower Cash flows from investing activities (4.8) (4.4) customer deposits and trade creditors (due to Cash flows from financing activities (1.5) (1.6) high level of sales in last part of the previous year) – £1.8m pension deficit payments (2013: £1.5m) Net cash flows (6.8) (1.9) – £1.0m tax paid (2013: £1.0m) Opening net funds 5.2 7.4 � Cash flows from investing activities includes: Exchange (0.5) (0.3) – £1.9m net capital expenditure (2013: £2.4m) Closing net (debt)/funds (2.1) 5.2 – £3.1m product development expenditure (2013: £2.2m), reflecting activity in all three divisions � Cash flows from financing activities includes: – £1.1m dividends paid (2013: £1.1m) 6 >>
Financial Review: Balance Sheet 2014 2013 Net assets £m £m Goodwill comprises amounts in respect � Intangible Goodwill 8.6 10.0 of Scientific Services businesses (Cerulean £7.3m and assets: Product development 7.1 5.2 Arista £1.3m after impairment of £1.6m in year) Property, plant & equipment 12.1 12.0 Property, plant and equipment includes £0.8m of � investment property Net working capital 14.6 11.7 Tax balance includes £0.2m (2013: £1.2m) of current � (exc. pensions & tax) tax payable Pension schemes (after tax) (15.2) (3.9) � Main equity movements in period include £11.9m of Current & deferred tax 0.8 0.3 actuarial losses (net of tax), £1.3m of translation (exc. pensions) losses and dividends paid of £1.1m Net (debt)/funds (2.1) 5.2 Equity 25.9 40.5 Net assets per share 128p 201p 7 >>
Divisional Trading Results 2014 2013 Sales £m £m Scientific Services 24.8 26.5 Packaging Machinery 40.5 44.3 Tobacco Machinery 24.6 34.4 Total 89.9 105.2 Underlying operating profit/(loss)* Scientific Services 1.8 1.1 Packaging Machinery 1.8 1.5 Tobacco Machinery (0.2) 2.9 Total 3.4 5.5 * Before non-underlying items 8 >>
Scientific Services: Business Overview Quality & Process Control Instrumentation � Market-leading testing/measuring instrumentation and machines – quality control instrumentation and smoke capture machines – carton testing, air sampling, pack seal testing International sales & service operations – based in UK, USA, China & India � Smoke & Tobacco Testing Services Leading smoke and tobacco constituent testing laboratory � � Fully equipped laboratory in Virginia, USA Customers include � Tobacco: Altria, British American Tobacco, China National Tobacco Corp, Eastern Tobacco, Imperial Tobacco, Japan Tobacco, Philip Morris International, independent and state-owned manufacturers Non-tobacco: Unilever, Procter & Gamble, Colgate, Ecolabs � 9 >>
Scientific Services: Operating Performance 2014 2013 Sales £24.8m £26.5m Operating profit* £1.8m £1.1m Return on sales* 7.2% 4.2% * Before reorganisation costs of £0.1m (2013: £0.1m) Quality & Process Control Instrumentation Sales strong but marginally down on previous year which benefited from large one-off project � � Demand for aftermarket products contributed 30% of sales Launch of e-cigarette testing instrument with strong market interest � � Technical innovation led to sales of specialised instruments � Favourable product mix led to improved margins Smoke & Tobacco Testing Services Lower sales, with no new regulatory testing requirements in USA; reduced costs led to slightly improved trading position � FDA changed prospective date for an announcement in respect of testing requirements for sixth and seventh time since 2012 � � Strategic review of business expected to be concluded in first half of 2015 10 >>
Scientific Services: New Products E-cigarette testing machine � – allows e-cigarette manufacturers to verify product designs and ensure compliance with market regulations as they develop – enables segregated testing of e-cigarettes, avoiding risk of contamination from tobacco products Lower capital costs than standard smoke capture � machines Positive response from the market � 11 >>
Packaging Machinery: Business Overview Leading supplier of complex high-speed packaging & processing equipment and � technical consultancy � Innovative technology tailored for specific niches within the following sectors – nutrition – beverages – healthcare – pharmaceutical – tobacco Key supplier to a number of leading FMCG and pharmaceutical multinationals � � Global presence with locations in UK, Netherlands, Canada and Singapore – increasing activity in emerging markets 12 >>
Packaging Machinery: Operating Performance 2014 2013 Sales £40.5m £44.3m Operating profit £1.8m £1.5m Return on sales 4.4% 3.4% Order intake increased by more than 20% in local currencies, with Asian region contributing strongly � � Sales in local currencies broadly flat Margins improved with strategy of introducing more standardised range of machines contributing to performance � – improvement diluted by under-utilisation of resources in early part of year � Growth in aftermarket targeted through concentration on key product applications “ Hygienic ” variants of standard machines well received by the market � Strong order book entering 2015 and well placed to continue to progress � 13 >>
Packaging Machinery: New Products � New Vento high-speed cartoning machine Incorporates a range of hygienic � design features that reduce the risk of microbial contamination Strong interest from a number of � current and prospective customers � First orders delivered 14 >>
Recommend
More recommend
